Please login to read the full article.
Scrip Regulatory Affairs
US FDA plans public workshop on evaluating medtech, pharma countermeasures for children
20 January 2012
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA invites comments on introducing UDIs in electronic data healthcare systems
- US FDA wants imaging device makers to show new products are safe for children
- US FDA April meeting to seek feedback on modernising drug trial regulations
- US FDA reopens opportunity to comment on reprocessing of reusable medical device
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
